Source:http://linkedlifedata.com/resource/pubmed/id/11099448
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2000-12-20
|
| pubmed:abstractText |
Most cases of familial presenile Alzheimer's disease are caused by mutations in the presenilin-1 (PSEN-1) gene, most of these mutations being missense mutations. A mutation in the splice donor site of intron 4 of PSEN-1 has been described recently which results in aberrant splicing of PSEN-1 mRNA, causing insertion of an additional amino acid, Thr113-114ins, into the protein. We studied the neuropathology of four cases bearing this mutation in an attempt to clarify the pathology of this hereditary form of Alzheimer's disease and to determine whether it differs from other familial forms of the disease. The disease presented as a progressive cognitive decline, myoclonus and seizures developing later in the disease, a feature common to PSEN-1-linked Alzheimer's disease. The course of the disease was relatively rapid, death occurring approximately 6 years after onset. Pathology in the intron 4 cases demonstrated a severe Alzheimer's disease pathology with abundant deposition of ss-amyloid (Ass) 1-42 senile plaques and the formation of neurofibrillary tangles. Amyloid angiopathy was present in these cases and was readily demonstrated by Ass 1-40 staining, particularly in the cerebellum. Cases with the intron 4 mutation appear clinically and pathologically similar to other cases of early-onset Alzheimer's disease bearing PSEN-1 mutations.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0006-8950
|
| pubmed:author |
pubmed-author:BallardC GCG,
pubmed-author:CordellBB,
pubmed-author:CrutsMM,
pubmed-author:De JongheCC,
pubmed-author:HallRR,
pubmed-author:Kumar-SinghSS,
pubmed-author:MatthewsPP,
pubmed-author:MorrisC MCM,
pubmed-author:PerryR HRH,
pubmed-author:RubinszteinD CDC,
pubmed-author:SingletonA BAB,
pubmed-author:TysonJJ,
pubmed-author:XuerebJ HJH,
pubmed-author:van BroeckhovenCC
|
| pubmed:issnType |
Print
|
| pubmed:volume |
123 Pt 12
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2467-74
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11099448-Adult,
pubmed-meshheading:11099448-Alzheimer Disease,
pubmed-meshheading:11099448-Cognition Disorders,
pubmed-meshheading:11099448-Creutzfeldt-Jakob Syndrome,
pubmed-meshheading:11099448-DNA Mutational Analysis,
pubmed-meshheading:11099448-Diagnosis, Differential,
pubmed-meshheading:11099448-Disease Progression,
pubmed-meshheading:11099448-Electroencephalography,
pubmed-meshheading:11099448-England,
pubmed-meshheading:11099448-Fatal Outcome,
pubmed-meshheading:11099448-Female,
pubmed-meshheading:11099448-Humans,
pubmed-meshheading:11099448-Introns,
pubmed-meshheading:11099448-Membrane Proteins,
pubmed-meshheading:11099448-Mutation,
pubmed-meshheading:11099448-Myoclonus,
pubmed-meshheading:11099448-Pedigree,
pubmed-meshheading:11099448-Presenilin-1,
pubmed-meshheading:11099448-Seizures
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.
|
| pubmed:affiliation |
Medical Research Council Neurochemical Pathology Unit, Institute for the Health of the Elderly and Department of Neuropathology, Newcastle General Hospital, Newcastle upon Tyne, UK.
|
| pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|